Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.
about
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.Targeted Treatment Options in Mastocytosis.Inhibition of the BET family of epigenetic reader proteins: A novel principle for modulating gene expression in IgE-activated mast cells.Midostaurin: a magic bullet that blocks mast cell expansion and activation.Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma
P2860
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of bromodomain- ...... target in mast cell leukemia.
@en
type
label
Identification of bromodomain- ...... target in mast cell leukemia.
@en
prefLabel
Identification of bromodomain- ...... target in mast cell leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Identification of bromodomain- ...... target in mast cell leukemia.
@en
P2093
J E Bradner
L Müllauer
S Cerny-Reiterer
P2860
P2888
P304
P356
10.1038/LEU.2015.138
P50
P577
2015-06-09T00:00:00Z
P6179
1001340407